5 February 2025
Novo Nordisk’s sales increased by 25% in Danish kroner and by 26% at constant exchange rates to DKK 290.4 billion in 2024 Profit and…
GSK delivers strong 2024 performance with further improvement to long-term growth outlook Strong sales and Core EPS growth reflecting accelerating momentum in Specialty Medicines…
SSE plc Q3 TRADING STATEMENT 5 FEBRUARY 2025 This Trading Statement updates on expectations for 2024/25 full year earnings, as well as strategic progress…
4 February 2025
Assura plc (“Assura” or the “Company”) Assura completes first net zero carbon developments Assura plc, the UK’s leading diversified healthcare REIT, is pleased to announce…
NWF Group plc NWF Group plc: half year results for the six months ended 30 November 2024 NWF Group plc (‘NWF’ or ‘the Group’),…
Improved organic sales in the first half of the fiscal year, despite a challenging environment Debra Crew, Chief Executive, said: Our fiscal 25 first…
3 February 2025
Baillie Gifford US Growth Trust plc (“USA” or the “Company”) Legal Entity Identifier: 213800UM1OUWXZPKE539 Result of Requisitioned General Meeting 3 February 2025 The Board of…
Imfinzi recommended for approval in the EU by CHMP as first and only immunotherapy for limited-stage small cell lung cancer Recommendation based on ADRIATIC Phase…